$6.26 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$29.43 - $138.52The lowest and highst price in the last 52 weeks.
0.0xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$6.26 Billion|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||+232.8%|
|Outstanding Shares||66.4 Million|
|Avg 30 Day Volume||750 Thousand|
|Earnings per Share||$0.00|
|Price to Sales Ratio||-|
|Price to Book Ratio||-|
|Revenue to Enterprise Value||-|
|EBIT to Enterprise Value||-|
|Total Debt to Enterprise Value||-|
|Debt to Equity||-|
|Quarterly Earnings Growth (YoY)||-|
|Return on Equity||-|
|Return on Assets||-|
|Return on Invested Capital||-|
7,095 shares sold (1 transactions)
25,338 shares sold (4 transactions)
In trading on Thursday, shares of Beam Therapeutics Inc (Symbol: BEAM) crossed above their 200 day moving average of $91.38, changing hands as high as $95.00 per share. Beam Therapeutics Inc shares...iShook Finance, 4 days ago
Beam Therapeutics} stock has undergone multiple analysts rating changes in the recent past. Beam Therapeutics Upgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm iss...Stock Market Daily, 6 days ago
Beam Therapeutics sees its Relative Strength Rating enter the elite 90-plus level.Investor''s Business Daily, 6 days ago